Alternatives to Absci

Biotech company focused on designing and developing novel biological solutions.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Developing novel protein-based solutions for industrial and therapeutic applications.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

A frontier AI lab for biology that designs and validates antibodies and proteins.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Botbiotech is developing AI-powered tools for biological research and drug discovery.

AI-powered platform that automates drug discovery through physical AI scientists and robotic experimentation.

Cryomatics develops AI-powered solutions for cryo-electron microscopy data analysis, accelerating drug discovery and structural biology.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

AI-powered platform for antibody discovery and development to create new medicines.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for personalized cell therapy development and manufacturing.

Advance every cancer decision.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

AI-powered platform for designing novel molecular structures for new medicines.

Biotechnology company

AI-powered platform accelerating biological research and drug discovery.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

AI platform for accelerating novel peptide therapeutic discovery and development.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

Compressing biology to develop the next generation of therapies.

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Narya Bio is developing novel therapeutic antibodies for challenging diseases.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

AI-enabled technology for cell biology research and biopharma development.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Mapping cell-cell communication at scale in human tissue.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.